Pneumologia
Organizações de manutenção da saúde (health maintenance organizations – HMO) israelenses afirmam que a terceira dose da vacina da Pfizer tem 86% de efetividade em maiores de 60 anos.
25 Ago, 2021 | 13:20hThird Pfizer dose 86% effective in over 60s, Israeli HMO says – Reuters
Comentário no Twitter
A third dose of Pfizer (PFE.N)/BioNTech's (https://t.co/eeCVHZYuCn) COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from a study of thousands of members. https://t.co/BQMzYmMHUt
— Reuters Health (@Reuters_Health) August 18, 2021
[Preprint] Estudo randomizado | Fluvoxamina reduz o risco de hospitalização em pacientes com Covid-19.
24 Ago, 2021 | 11:54hConteúdos relacionados:
Comentário no Twitter
@TogetherTrial Manuscript Pre-print regarding #Fluvoxamine for early #COVID19 is online athttps://t.co/teHqMlowld
demonstrating ~30% relative reduction in ER visits / hospitalizations with fluvoxamine 100mg 2x/day in a 10-site, double-blind randomized trial. #IDtwitter pic.twitter.com/727by0lqft— David Boulware, MD MPH (@boulware_dr) August 23, 2021
Reforço de vacinas contra Covid-19: o que se sabe e quem está fazendo o quê.
24 Ago, 2021 | 11:52hCovid-19 booster vaccines: What we know and who’s doing what – The BMJ
Opinião | O FDA realmente precisava demorar tudo isso – “Se a aprovação das vacinas parece tão escrupulosa, é porque a alternativa a isso é pior.”
24 Ago, 2021 | 11:49hThe FDA Really Did Have to Take This Long – The Atlantic
Como a variante Delta evoluirá? Isto é o que a teoria nos diz.
24 Ago, 2021 | 11:48hHow will Delta evolve? Here’s what the theory tells us – The Conversation
Vacinas contra COVID protegem da variante Delta, mas sua eficácia diminui com o tempo.
24 Ago, 2021 | 11:47hCOVID vaccines protect against Delta, but their effectiveness wanes – Nature
Estudo original: [Preprint] Pfizer vaccine effectiveness against Delta declines faster than AstraZeneca, both offering the same protection after 4 months.
Como fazer: considerações sobre transplante pulmonar para pacientes com COVID-19.
24 Ago, 2021 | 11:45hHow I Do It: Considering lung transplantation for patients with COVID-19 – CHEST
Conteúdos relacionados:
Report: Lung transplantation for 3 patients with severe COVID-19
M-A | Assincronia paciente-ventilador, impacto nos desfechos clínicos e eficácia das intervenções.
24 Ago, 2021 | 11:32hEstudo randomizado | Posição pronada reduz a necessidade de entubação em pacientes com COVID-19.
23 Ago, 2021 | 13:27hComentário convidado: Awake prone positioning in COVID-19: is tummy time ready for prime time?
Conteúdos relacionados:
Comentário no Twitter
Awake prone positioning of pts w/ hypoxaemic respiratory failure due to #COVID19 reduces incidence of treatment failure & need for intubation w/o any signal of harm
Meta-trial from the Awake Prone Positioning Meta-Trial Group https://t.co/GuDdjPnVps pic.twitter.com/ZS08uQN1gE
— The Lancet Respiratory Medicine (@LancetRespirMed) August 21, 2021
[Preprint] Estudo mostra que as infecções por SARS-CoV-2 em indivíduos já vacinados (“breakthrough infections”) são menos transmissíveis que infecções por SARS-CoV-2 em indivíduos não vacinados.
23 Ago, 2021 | 13:23h
Comentário no Twitter (fio – clique para saber mais)
Did you hear vaccinated people with Delta “have just as much virus in their nose so are just as infectious as unvaccinated”?
Turns out vaccinated people have significantly less culturable virus present at the same Ct count
They are LESS INFECTIOUS 💥 https://t.co/OX0Ul0ntWc pic.twitter.com/3vDQSJ6j84
— Alasdair Munro (@apsmunro) August 22, 2021